BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30573361)

  • 1. CFTR activation suppresses glioblastoma cell proliferation, migration and invasion.
    Zhong X; Chen HQ; Yang XL; Wang Q; Chen W; Li C
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1279-1285. PubMed ID: 30573361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swelling-induced chloride current in glioblastoma proliferation, migration, and invasion.
    Wong R; Chen W; Zhong X; Rutka JT; Feng ZP; Sun HS
    J Cell Physiol; 2018 Jan; 233(1):363-370. PubMed ID: 28262948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
    Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
    Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.
    Zheng Q; Han L; Dong Y; Tian J; Huang W; Liu Z; Jia X; Jiang T; Zhang J; Li X; Kang C; Ren H
    Neuro Oncol; 2014 Sep; 16(9):1229-43. PubMed ID: 24861878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-124 Acts as a Tumor Suppressor in Glioblastoma via the Inhibition of Signal Transducer and Activator of Transcription 3.
    Li W; Huang H; Su J; Ji X; Zhang X; Zhang Z; Wang H
    Mol Neurobiol; 2017 May; 54(4):2555-2561. PubMed ID: 26993295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.
    Liu X; Gao Q; Zhao N; Zhang X; Cui W; Sun J; Fu J; Hao J
    Mol Carcinog; 2018 Apr; 57(4):494-502. PubMed ID: 29240260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
    Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.
    Mukthavaram R; Ouyang X; Saklecha R; Jiang P; Nomura N; Pingle SC; Guo F; Makale M; Kesari S
    J Transl Med; 2015 Aug; 13():269. PubMed ID: 26283544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells.
    Li W; Fu X; Liu R; Wu C; Bai J; Xu Y; Zhao Y; Xu Y
    Oncol Res; 2013; 21(2):111-20. PubMed ID: 24406047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells.
    Senft C; Priester M; Polacin M; Schröder K; Seifert V; Kögel D; Weissenberger J
    J Neurooncol; 2011 Feb; 101(3):393-403. PubMed ID: 20589525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TROY signals through JAK1-STAT3 to promote glioblastoma cell migration and resistance.
    Ding Z; Kloss JM; Tuncali S; Tran NL; Loftus JC
    Neoplasia; 2020 Sep; 22(9):352-364. PubMed ID: 32629176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RBPJ contributes to the malignancy of glioblastoma and induction of proneural-mesenchymal transition via IL-6-STAT3 pathway.
    Zhang G; Tanaka S; Jiapaer S; Sabit H; Tamai S; Kinoshita M; Nakada M
    Cancer Sci; 2020 Nov; 111(11):4166-4176. PubMed ID: 32885530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.
    Hong L; Ya-Wei L; Hai W; Qiang Z; Jun-Jie L; Huang A; Song-Tao Q; Yun-Tao L
    J Neurooncol; 2016 May; 128(1):35-45. PubMed ID: 26970980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Large-Conductance Calcium-Activated Potassium Channels in Human Glioblastoma Stem-Like Cells and Their Role in Cell Migration.
    Rosa P; Sforna L; Carlomagno S; Mangino G; Miscusi M; Pessia M; Franciolini F; Calogero A; Catacuzzeno L
    J Cell Physiol; 2017 Sep; 232(9):2478-2488. PubMed ID: 27606467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.
    Cheng YC; Tsai WC; Sung YC; Chang HH; Chen Y
    Cell Physiol Biochem; 2018; 45(2):819-831. PubMed ID: 29414809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways.
    Li S; Chen X; Mao L; Zahid KR; Wen J; Zhang L; Zhang M; Duan J; Duan J; Yin X; Wang Y; Zhao L; Tang X; Wang X; Xu G
    Brain Res; 2018 Aug; 1692():154-162. PubMed ID: 29782850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitidine chloride suppresses epithelial-mesenchymal transition and stem cell-like properties in glioblastoma by regulating JAK2/STAT3 signaling.
    Jia M; Wang Y; Guo Y; Yu P; Sun Y; Song Y; Zhao L
    Cancer Med; 2021 May; 10(9):3113-3128. PubMed ID: 33788424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway.
    Hou J; Lv A; Deng Q; Zhang G; Hu X; Cui H
    Oncol Rep; 2019 Feb; 41(2):753-764. PubMed ID: 30431125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.